STZ/CFA-Induced Diabetic Ocular Complications Model in Rats
Huateng Bio provides STZ/CFA-induced diabetic ocular models in SD rats. Features 16-week retinopathy/cataract progression, OCT validation, and 85% survival rate. Ideal for anti-VEGF drug development. Download protocols.